Coronation Fund Managers Ltd. Baxter International Inc Transaction History

Coronation Fund Managers Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$39.98 - $47.68 $3.27 Million - $3.9 Million	-81,862 Reduced 65.86%	42,427 $1.93 Million
Q1 2023 May 05, 2023	SELL	$37.58 - $52.57 $1.8 Million - $2.52 Million	-47,963 Reduced 27.84%	124,289 $5.04 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $3.22 Million - $3.73 Million	64,710 Added 60.17%	172,252 $8.78 Million
Q3 2022 Oct 20, 2022	BUY	$53.86 - $66.8 $197,127 - $244,488	3,660 Added 3.52%	107,542 $5.79 Million
Q1 2022 May 03, 2022	SELL	$76.85 - $89.45 $191,125 - $222,462	-2,487 Reduced 2.34%	103,882 $8.06 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $682,166 - $797,614	9,148 Added 9.41%	106,369 $9.13 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $6.83 Million - $7.74 Million	92,600 Added 2003.9%	97,221 $7.82 Million
Q2 2021 Jul 27, 2021	BUY	$80.5 - $88.01 $371,990 - $406,694	4,621 New	4,621 $372,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.